Metformin and sitAgliptin in patients with impAired glucose tolerance and a recent TIA or minor ischemic Stroke (MAAS): study protocol for a randomized controlled trial.
about
Dipeptidyl-peptidase (DPP)-4 inhibitors and glucagon-like peptide (GLP)-1 analogues for prevention or delay of type 2 diabetes mellitus and its associated complications in people at increased risk for the development of type 2 diabetes mellitus.An update on DPP-4 inhibitors in the management of type 2 diabetes.
P2860
Metformin and sitAgliptin in patients with impAired glucose tolerance and a recent TIA or minor ischemic Stroke (MAAS): study protocol for a randomized controlled trial.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
Metformin and sitAgliptin in p ...... a randomized controlled trial.
@ast
Metformin and sitAgliptin in p ...... a randomized controlled trial.
@en
type
label
Metformin and sitAgliptin in p ...... a randomized controlled trial.
@ast
Metformin and sitAgliptin in p ...... a randomized controlled trial.
@en
prefLabel
Metformin and sitAgliptin in p ...... a randomized controlled trial.
@ast
Metformin and sitAgliptin in p ...... a randomized controlled trial.
@en
P2093
P2860
P1433
P1476
Metformin and sitAgliptin in p ...... a randomized controlled trial.
@en
P2093
Adrienne A M Zandbergen
Diederik W J Dippel
Elizabeth Osei
Heleen M den Hertog
Hester F Lingsma
Laus J M M Mulder
Paul J A M Brouwers
Peter J Koudstaal
Susanne Fonville
P2860
P2888
P356
10.1186/S13063-015-0882-Z
P577
2015-08-05T00:00:00Z
P5875
P6179
1038771098